Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Powers

Showing results (1211-1220 of 1,238) with videos related to

Pageof 124
Sort By:
MMWR. Morbidity and Mortality Weekly Report|April 1, 2016
Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure--United States, 2016Emily E Petersen, Kara N D Polen, Dana Meaney-Delman, et al.
Mbio|May 6, 2026
Loss of nsp14-exonuclease activity impairs the replication, proofreading, fitness, and pathogenesis of SARS-CoV-2Jordan Anderson-Daniels, Meghan V Diefenbacher, Boyd L Yount, et al.
Cell Reports|October 20, 2023
Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in miceDavid R Martinez, Alexandra Schäfer, Tyler D Gavitt, et al.
The American Journal of Tropical Medicine and Hygiene|July 27, 2022
Neurological Disease Associated with Chikungunya in IndonesiaKhin S A Myint, Arthur H P Mawuntu, Sotianingsih Haryanto, et al.
MMWR. Morbidity and Mortality Weekly Report|July 29, 2016
Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure - United States, July 2016Titilope Oduyebo, Irogue Igbinosa, Emily E Petersen, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2Yupeng Feng, Meng Yuan, John M Powers, et al.
Biorxiv : the Preprint Server for Biology|March 28, 2024
Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccinationWilliam N Voss, Michael A Mallory, Patrick O Byrne, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2022
Fc mediated pan-sarbecovirus protection after alphavirus vector vaccinationLily E Adams, Sarah R Leist, Kenneth H Dinnon, et al.
JAMA Network Open|August 10, 2022
Durability of Heterologous and Homologous COVID-19 Vaccine BoostsC Sabrina Tan, Ai-Ris Y Collier, Jingyou Yu, et al.
Cell Reports|March 31, 2023
Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccinationLily E Adams, Sarah R Leist, Kenneth H Dinnon, et al.
Pageof 124

Showing results (1211-1220 of 1,238) with videos related to

Sort By:
Pageof 124
MMWR. Morbidity and Mortality Weekly Report|April 1, 2016
Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure--United States, 2016Emily E Petersen, Kara N D Polen, Dana Meaney-Delman, et al.
Mbio|May 6, 2026
Loss of nsp14-exonuclease activity impairs the replication, proofreading, fitness, and pathogenesis of SARS-CoV-2Jordan Anderson-Daniels, Meghan V Diefenbacher, Boyd L Yount, et al.
Cell Reports|October 20, 2023
Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in miceDavid R Martinez, Alexandra Schäfer, Tyler D Gavitt, et al.
The American Journal of Tropical Medicine and Hygiene|July 27, 2022
Neurological Disease Associated with Chikungunya in IndonesiaKhin S A Myint, Arthur H P Mawuntu, Sotianingsih Haryanto, et al.
MMWR. Morbidity and Mortality Weekly Report|July 29, 2016
Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure - United States, July 2016Titilope Oduyebo, Irogue Igbinosa, Emily E Petersen, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2Yupeng Feng, Meng Yuan, John M Powers, et al.
Biorxiv : the Preprint Server for Biology|March 28, 2024
Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccinationWilliam N Voss, Michael A Mallory, Patrick O Byrne, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2022
Fc mediated pan-sarbecovirus protection after alphavirus vector vaccinationLily E Adams, Sarah R Leist, Kenneth H Dinnon, et al.
JAMA Network Open|August 10, 2022
Durability of Heterologous and Homologous COVID-19 Vaccine BoostsC Sabrina Tan, Ai-Ris Y Collier, Jingyou Yu, et al.
Cell Reports|March 31, 2023
Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccinationLily E Adams, Sarah R Leist, Kenneth H Dinnon, et al.
Pageof 124